{{Rsnum
|rsid=2180566
|Gene=DEFB122
|Chromosome=20
|position=31431051
|Orientation=plus
|GMAF=0.4146
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=DEFB122
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 9.9 | 53.2 | 36.9
| HCB | 7.3 | 42.3 | 50.4
| JPT | 10.6 | 32.7 | 56.6
| YRI | 50.7 | 41.1 | 8.2
| ASW | 40.4 | 49.1 | 10.5
| CHB | 7.3 | 42.3 | 50.4
| CHD | 7.3 | 32.1 | 60.6
| GIH | 5.9 | 43.6 | 50.5
| LWK | 33.6 | 50.9 | 15.5
| MEX | 14.0 | 40.4 | 45.6
| MKK | 25.6 | 47.4 | 26.9
| TSI | 8.8 | 52.9 | 38.2
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2180566
|Name_s=
|Gene_s=DEFB123
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363839
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2180566
|overall_frequency_n=75
|overall_frequency_d=128
|overall_frequency=0.585938
|n_genomes=41
|n_genomes_annotated=0
|n_haplomes=61
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}